Cargando…

Effect of Mass Artesunate-Amodiaquine Distribution on Mortality of Patients With Ebola Virus Disease During West African Outbreak

BACKGROUND: Experiments in vitro have shown that the drug amodiaquine may inhibit Ebola virus activity. During the Ebola virus disease (EVD) epidemic in West Africa in 2014–2016, 2 mass drug administrations (MDAs) of artesunate-amodiaquine (ASAQ) were implemented to decrease the burden of malaria. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garbern, Stephanie C, Yam, Derrick, Aluisio, Adam R, Cho, Daniel K, Kennedy, Stephen B, Massaquoi, Moses, Sahr, Foday, Perera, Shiromi M, Levine, Adam C, Liu, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Editor's Choice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602760/ https://www.ncbi.nlm.nih.gov/pubmed/31281856 http://dx.doi.org/10.1093/ofid/ofz250

Ejemplares similares

Association between oral antimalarial medication administration and mortality among patients with Ebola virus disease: a multisite cohort study
por: Abel, Logan, et al.
Publicado: (2022)

Association between multivitamin supplementation and mortality among patients with Ebola virus disease: An international multisite cohort study
por: Yam, Derrick, et al.
Publicado: (2020)

Fixed dose artesunate amodiaquine – a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine
por: Ogutu, Bernhards, et al.
Publicado: (2014)

Post-Ebola Syndrome, Sierra Leone
por: Scott, Janet T., et al.
Publicado: (2016)

Population pharmacokinetics of artesunate and amodiaquine in African children
por: Stepniewska, Kasia, et al.
Publicado: (2009)

Factors associated with length of stay and treatment outcome of Ebola patients treated at an Ebola treatment center in Sierra Leone during the peak period of the West African Ebola outbreak 2013–2016
por: Kangbai, Jia Bainga, et al.
Publicado: (2021)

Evaluation of the Comparative Efficacy and Safety of Artemether-Lumefantrine, Artesunate-Amodiaquine and Artesunate-Amodiaquine-Chlorpheniramine (Artemoclo™) for the Treatment of Acute Uncomplicated Malaria in Nigerian Children
por: Falade, C.O., et al.
Publicado: (2014)

Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania
por: Mutabingwa, Theonest K., et al.
Publicado: (2009)

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
por: Orrell, Catherine, et al.
Publicado: (2008)

Artesunate/Amodiaquine Malaria Treatment for Equatorial Guinea (Central Africa)
por: Charle, Pilar, et al.
Publicado: (2013)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
por: Raobela, Oméga, et al.
Publicado: (2018)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia
por: Mairet-Khedim, Melissa, et al.
Publicado: (2020)

Effect of Recombinant Vesicular Stomatitis Virus–Zaire Ebola Virus Vaccination on Ebola Virus Disease Illness and Death, Democratic Republic of the Congo
por: Rupani, Neil, et al.
Publicado: (2022)

Artesunate – amodiaquine combination therapy for falciparum malaria in young Gabonese children
por: Oyakhirome, Sunny, et al.
Publicado: (2007)

Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine
por: Amin, N’Cho Christophe, et al.
Publicado: (2012)

An Open Label, Randomised Trial of Artesunate+Amodiaquine, Artesunate+Chlorproguanil-Dapsone and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria
por: Owusu-Agyei, Seth, et al.
Publicado: (2008)

In Vivo Activity of Amodiaquine against Ebola Virus Infection
por: DeWald, Lisa Evans, et al.
Publicado: (2019)

Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial
por: Djallé, Djibrine, et al.
Publicado: (2014)

Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018
por: Dentinger, Catherine M., et al.
Publicado: (2021)

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India
por: Anvikar, Anupkumar R, et al.
Publicado: (2012)

Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi
por: Amuasi, John H, et al.
Publicado: (2011)

Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville
por: Ndounga, Mathieu, et al.
Publicado: (2013)

Efficacy of artesunate-amodiaquine for the treatment of acute uncomplicated falciparum malaria in southern Mauritania
por: Ouldabdallahi, Mohamed, et al.
Publicado: (2014)

Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine
por: Adjei, George O, et al.
Publicado: (2012)

SARS-CoV-2 vaccine responses following CD20-depletion treatment in patients with haematological and rheumatological disease: a West Midlands Research Consortium study
por: Shields, Adrian M, et al.
Publicado: (2021)

RNA polymerase pausing at a protein roadblock can enhance transcriptional interference by promoter occlusion
por: Hao, Nan, et al.
Publicado: (2019)

Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination
por: Ntale, Muhammad, et al.
Publicado: (2009)

Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali
por: Tekete, Mamadou M, et al.
Publicado: (2011)

School-aged children based seasonal malaria chemoprevention using artesunate-amodiaquine in Mali
por: Thera, Mahamadou A., et al.
Publicado: (2018)

Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children
por: Yeka, Adoke, et al.
Publicado: (2014)

Novel amodiaquine derivatives potently inhibit Ebola virus infection
por: Sakurai, Yasuteru, et al.
Publicado: (2018)

Artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers
por: Koko, Victor S., et al.
Publicado: (2022)

Beyond Ebola treatment units: severe infection temporary treatment units as an essential element of Ebola case management during an outbreak
por: Janke, Christian, et al.
Publicado: (2017)

Establishing the prevalence of common tissue‐specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection
por: Richter, Alex G., et al.
Publicado: (2021)

Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers
por: Navaratnam, Visweswaran, et al.
Publicado: (2009)

A pilot study on quality of artesunate and amodiaquine tablets used in the fishing community of Tema, Ghana
por: Affum, Andrews O, et al.
Publicado: (2013)

In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014
por: Paczkowski, Magdalena, et al.
Publicado: (2016)

Notch signalling is a potential resistance mechanism of progenitor cells within patient‐derived prostate cultures following ROS‐inducing treatments
por: Packer, John R., et al.
Publicado: (2019)

Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether–lumefantrine and artesunate–amodiaquine in Africa
por: Okell, Lucy C, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ref61kl4fkcl96nh4i5kvv1phd